Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline EGFR T790M Mutation
{{output}}
Introduction: A subset of lung adenocarcinomas (ADs) has been found to have somatic activating mutations in the tyrosine kinase domain of the EGFR gene, associated with response to EGFR tyrosine kinase inhibitor therapy. Rare ger... ...
